DOZZA, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 413
EU - Europa 306
AS - Asia 178
AF - Africa 22
OC - Oceania 5
SA - Sud America 2
Totale 926
Nazione #
US - Stati Uniti d'America 413
IT - Italia 105
SE - Svezia 53
VN - Vietnam 52
DE - Germania 48
SG - Singapore 42
GB - Regno Unito 40
CN - Cina 35
IN - India 26
IE - Irlanda 17
TG - Togo 10
CI - Costa d'Avorio 9
JO - Giordania 9
PH - Filippine 8
FI - Finlandia 7
AU - Australia 5
BG - Bulgaria 5
CZ - Repubblica Ceca 5
FR - Francia 5
RU - Federazione Russa 5
CH - Svizzera 4
UA - Ucraina 3
EE - Estonia 2
IL - Israele 2
ZA - Sudafrica 2
AR - Argentina 1
BD - Bangladesh 1
CL - Cile 1
ES - Italia 1
HR - Croazia 1
LT - Lituania 1
LU - Lussemburgo 1
MK - Macedonia 1
NG - Nigeria 1
NO - Norvegia 1
RO - Romania 1
SA - Arabia Saudita 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 926
Città #
Chandler 83
Singapore 38
Ashburn 36
Southend 35
Fairfield 27
Dong Ket 26
Bologna 21
Dublin 17
Princeton 16
Redmond 16
Seattle 14
Cambridge 13
Houston 13
Wilmington 12
Woodbridge 12
Hyderabad 10
Lomé 10
New York 10
Abidjan 9
Amman 9
Falls Church 9
Bremen 8
Santa Clara 8
Beijing 7
Des Moines 7
Helsinki 7
Milan 7
Berlin 6
San Diego 6
Turin 6
Florence 5
Sofia 5
Ann Arbor 4
Bern 4
Fabriano 4
Los Angeles 4
Washington 4
Melbourne 3
Pianoro 3
Rome 3
San Felice sul Panaro 3
Stilo 3
Verona 3
Brno 2
Cagliari 2
Cernusco sul Naviglio 2
Guangzhou 2
Hangzhou 2
Jerusalem 2
Legnago 2
Munich 2
Nanjing 2
Redwood City 2
Saint Petersburg 2
San Francisco 2
Shrewsbury 2
Treviso 2
Westminster 2
Wuhan 2
Abano Terme 1
Abeokuta 1
Ahmedabad 1
Buffalo 1
Casalecchio di Reno 1
Changchun 1
Dearborn 1
Esslingen am Neckar 1
Forlì 1
Gazipur 1
Jiaxing 1
Jinan 1
Kiev 1
Kilburn 1
Kuban 1
Kunming 1
Leawood 1
Liverpool 1
Madrid 1
Mason 1
Massafra 1
Medford 1
Mesagne 1
Monmouth Junction 1
Moscow 1
Mumbai 1
Norwalk 1
Olalla 1
Oslo 1
Padova 1
Penrith 1
Porto Recanati 1
Pune 1
Shanghai 1
Shenyang 1
Shenzhen 1
Striano 1
Tallinn 1
Trenton 1
Xi'an 1
Zagreb 1
Totale 619
Nome #
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study 131
A real-world efficacy and safety analysis of combined carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed/refractory multiple myeloma 127
Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study 122
Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma 116
Is there a relationship between self-efficacy, disability, pain and sociodemographic characteristics in chronic low back pain? A multicenter retrospective analysis 112
Maintenance therapy with bortezomib and dexamethasone after autotransplantation for high-risk multiple myeloma 107
null 98
Standardization of 18F-FDG-PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma 85
Role of serum-free light chain assay for defining response and progression in immunoglobulin secretory multiple myeloma 40
Subcutaneous bortezomib-containing regimens as up-front treatment of newly diagnosed transplant-eligible multiple myeloma patients: a retrospective, non-interventional observational study 18
Abstract 2700: Negative selective pressure exerted by maintenance therapy promotes the extinction of sub-clones carrying high-risk lesions in multiple myeloma 8
Totale 964
Categoria #
all - tutte 3.114
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.114


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202066 0 0 0 4 10 7 9 12 11 8 5 0
2020/2021138 8 0 2 2 0 1 0 23 17 2 13 70
2021/2022257 2 10 23 38 16 17 12 19 6 38 42 34
2022/2023287 28 39 15 51 9 24 7 15 52 10 23 14
2023/2024105 15 14 8 6 12 27 5 6 3 1 4 4
2024/202598 25 36 34 3 0 0 0 0 0 0 0 0
Totale 964